Brexit & COVID-19 Bring New Roles For UK Biological Medicines Control Lab
Newly Standalone NIBSC To Help Standardize Vaccine Response Testing
One effect of Brexit is that the UK’s National Institute for Biological Standards and Control will have additional responsibilities from next year in terms of the independent batch testing and release of products such as vaccines and medicines derived from human blood and plasma in Great Britain.
